XML 24 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]    
Revenue
Operating expenses    
Research and development, net of contract expense reimbursements 3,517,093 1,148,712
General and administrative 1,046,854 538,796
Legal and professional 1,328,435 866,770
Total operating expenses 5,892,382 2,554,278
Loss from operations (5,892,382) (2,554,278)
Other income (expense)    
Interest income 79,117
Finance fee (104,245)
Change in fair value of derivative liabilities 2,216,488 94,025
Gain on sale of marketable securities 4,970
Change in fair value of marketable securities 71,568
Loss on settlement of convertible debt (477,221)
Gain on settlement of accounts payable 328,687
Gain on forgiveness of Paycheck Protection Program note payable 73,007
Total other expense (700,341) (474,170)
Net loss (6,592,723) (3,028,448)
Dividend on Series A Preferred Stock (71,009)
Net loss attributable to common stockholders $ (6,592,723) $ (3,099,457)
Weighted average common shares outstanding basic 14,919,484 10,351,046
Weighted average common shares outstanding diluted 14,919,484 10,351,046
Net loss per shares - basic $ (0.44) $ (0.29)
Net loss per shares - diluted $ (0.44) $ (0.29)
Related Party [Member]    
Other income (expense)    
Interest expense $ (6,825) $ (52,010)
Nonrelated Party [Member]    
Other income (expense)    
Interest expense $ (2,484,193) $ (917,879)